- Home
- CELC vs GROY Comparison
CELC vs GROY Comparison
Compare CELC & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- GROY
- Stock Information
- Founded
- CELC 2011
- GROY 2020
- Country
- CELC United States
- GROY Canada
- Employees
- CELC N/A
- GROY N/A
- Industry
- CELC Medical Specialities
- GROY
- Sector
- CELC Health Care
- GROY
- Exchange
- CELC Nasdaq
- GROY Nasdaq
- Market Cap
- CELC 327.3M
- GROY 269.3M
- IPO Year
- CELC 2017
- GROY 2021
- Fundamental
- Price
- CELC $11.62
- GROY $1.90
- Analyst Decision
- CELC Strong Buy
- GROY Strong Buy
- Analyst Count
- CELC 5
- GROY 4
- Target Price
- CELC $30.80
- GROY $3.31
- AVG Volume (30 Days)
- CELC 148.5K
- GROY 1.7M
- Earning Date
- CELC 05-14-2025
- GROY 05-07-2025
- Dividend Yield
- CELC N/A
- GROY N/A
- EPS Growth
- CELC N/A
- GROY N/A
- EPS
- CELC N/A
- GROY N/A
- Revenue
- CELC N/A
- GROY $10,347,000.00
- Revenue This Year
- CELC N/A
- GROY $88.55
- Revenue Next Year
- CELC N/A
- GROY $52.87
- P/E Ratio
- CELC N/A
- GROY N/A
- Revenue Growth
- CELC N/A
- GROY 99.94
- 52 Week Low
- CELC $7.58
- GROY $1.16
- 52 Week High
- CELC $19.77
- GROY $1.96
- Technical
- Relative Strength Index (RSI)
- CELC 64.24
- GROY 70.67
- Support Level
- CELC $10.50
- GROY $1.81
- Resistance Level
- CELC $10.88
- GROY $1.91
- Average True Range (ATR)
- CELC 0.62
- GROY 0.07
- MACD
- CELC 0.05
- GROY 0.02
- Stochastic Oscillator
- CELC 90.17
- GROY 87.25
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.